Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia : Results from the US intergroup phase III trial E2997
- Author
- GREVER, Michael R; LUCAS, David M; PAIETTA, Elisabeth; JELINEK, Diane F; GRIBBEN, John G; BYRD, John C; DEWALD, Gordon W; NEUBERG, Donna S; REED, John C; KITADA, Shinichi; FLINN, Ian W; TALLMAN, Martin S; APPELBAUM, Frederick R; LARSON, Richard A
[1] Eastern Cooperative Oncology Group, United States
[2] Cancer and Leukemia Group B, United States
[3] Southwest Oncology Group, United States
[4] Division of Hematology-Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States
[5] Department of Cytogenetics, Mayo Clinic, United States
[6] Mayo Clinic College of Medicine, Rochester, MN, United States
[7] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, United States
[8] Burnham Institute for Medical Research, La Jolla, CA, United States
[9] Department of Oncology, Johns Hopkins University, Baltimore, MD, United States
[10] Division of Hematology-Oncology, Northwestern University Feinberg School of Medicine, United States
[11] The University of Chicago, Chicago IL, United States
[12] Fred Hutchinson Cancer Research Center, Seattle, WA, United States
[13] Our Lady of Mercy Comprehensive Cancer Center, Bronx, NY, United States
[14] Barts and The London School of Medicine, London, United Kingdom - Source
Journal of clinical oncology. 2007, Vol 25, Num 7, pp 799-804, 6 p ; ref : 35 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Cancérologie Chimiothérapie Essai clinique phase III Génétique Homme Pronostic Traitement Leucémie lymphoïde chronique Hémopathie maligne
- Keyword (en)
- Cancerology Chemotherapy Phase III trial Genetics Human Prognosis Treatment Chronic lymphocytic leukemia Malignant hemopathy
- Keyword (es)
- Cancerología Quimioterapia Ensayo clínico fase III Genética Hombre Pronóstico Tratamiento Leucemia linfoidea Hemopatía maligna
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18602618
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2006.08.3089 
https://dx.doi.org/10.1200/JCO.2006.08.3089
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.08.3089\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:178:\"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia : Results from the US intergroup phase III trial E2997\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"799\";s:8:\"\u0000*\u0000epage\";s:3:\"804\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GREVER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"LUCAS, David M\";i:1;s:18:\"PAIETTA, Elisabeth\";i:2;s:16:\"JELINEK, Diane F\";i:3;s:15:\"GRIBBEN, John G\";i:4;s:12:\"BYRD, John C\";i:5;s:16:\"DEWALD, Gordon W\";i:6;s:16:\"NEUBERG, Donna S\";i:7;s:12:\"REED, John C\";i:8;s:16:\"KITADA, Shinichi\";i:9;s:12:\"FLINN, Ian W\";i:10;s:17:\"TALLMAN, Martin S\";i:11;s:22:\"APPELBAUM, Frederick R\";i:12;s:17:\"LARSON, Richard A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:178:\"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia : Results from the US intergroup phase III trial E2997\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.08.3089\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:178:\"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia : Results from the US intergroup phase III trial E2997\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"799\";s:8:\"\u0000*\u0000epage\";s:3:\"804\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GREVER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"LUCAS, David M\";i:1;s:18:\"PAIETTA, Elisabeth\";i:2;s:16:\"JELINEK, Diane F\";i:3;s:15:\"GRIBBEN, John G\";i:4;s:12:\"BYRD, John C\";i:5;s:16:\"DEWALD, Gordon W\";i:6;s:16:\"NEUBERG, Donna S\";i:7;s:12:\"REED, John C\";i:8;s:16:\"KITADA, Shinichi\";i:9;s:12:\"FLINN, Ian W\";i:10;s:17:\"TALLMAN, Martin S\";i:11;s:22:\"APPELBAUM, Frederick R\";i:12;s:17:\"LARSON, Richard A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:178:\"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia : Results from the US intergroup phase III trial E2997\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.08.3089\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.08.3089\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:178:\"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia : Results from the US intergroup phase III trial E2997\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"799\";s:8:\"\u0000*\u0000epage\";s:3:\"804\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GREVER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"LUCAS, David M\";i:1;s:18:\"PAIETTA, Elisabeth\";i:2;s:16:\"JELINEK, Diane F\";i:3;s:15:\"GRIBBEN, John G\";i:4;s:12:\"BYRD, John C\";i:5;s:16:\"DEWALD, Gordon W\";i:6;s:16:\"NEUBERG, Donna S\";i:7;s:12:\"REED, John C\";i:8;s:16:\"KITADA, Shinichi\";i:9;s:12:\"FLINN, Ian W\";i:10;s:17:\"TALLMAN, Martin S\";i:11;s:22:\"APPELBAUM, Frederick R\";i:12;s:17:\"LARSON, Richard A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:178:\"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia : Results from the US intergroup phase III trial E2997\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.08.3089\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:178:\"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia : Results from the US intergroup phase III trial E2997\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"799\";s:8:\"\u0000*\u0000epage\";s:3:\"804\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GREVER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"LUCAS, David M\";i:1;s:18:\"PAIETTA, Elisabeth\";i:2;s:16:\"JELINEK, Diane F\";i:3;s:15:\"GRIBBEN, John G\";i:4;s:12:\"BYRD, John C\";i:5;s:16:\"DEWALD, Gordon W\";i:6;s:16:\"NEUBERG, Donna S\";i:7;s:12:\"REED, John C\";i:8;s:16:\"KITADA, Shinichi\";i:9;s:12:\"FLINN, Ian W\";i:10;s:17:\"TALLMAN, Martin S\";i:11;s:22:\"APPELBAUM, Frederick R\";i:12;s:17:\"LARSON, Richard A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:178:\"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia : Results from the US intergroup phase III trial E2997\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.08.3089\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:178:\"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia : Results from the US intergroup phase III trial E2997\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"799\";s:8:\"\u0000*\u0000epage\";s:3:\"804\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GREVER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"LUCAS, David M\";i:1;s:18:\"PAIETTA, Elisabeth\";i:2;s:16:\"JELINEK, Diane F\";i:3;s:15:\"GRIBBEN, John G\";i:4;s:12:\"BYRD, John C\";i:5;s:16:\"DEWALD, Gordon W\";i:6;s:16:\"NEUBERG, Donna S\";i:7;s:12:\"REED, John C\";i:8;s:16:\"KITADA, Shinichi\";i:9;s:12:\"FLINN, Ian W\";i:10;s:17:\"TALLMAN, Martin S\";i:11;s:22:\"APPELBAUM, Frederick R\";i:12;s:17:\"LARSON, Richard A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:178:\"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia : Results from the US intergroup phase III trial E2997\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
